Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP-675,206 in HIV Infection
NCT00488995Phase 2Withdrawn
- Sponsor
- Pfizer
- Start
- Jul 2007
01
Overview
A Phase 2 trial of tremelimumab in human immunodeficiency virus infection (HIV), sponsored by Pfizer. Planned start Jul 2007; status: withdrawn.
02
Drugs
tremelimumab
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00488995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00488995.